Chinese Drug Companies Expected To Outperform Device Makers In 2010 - Morgan Stanley Valuation Overview
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - With a strong IPO performance for the Chinese healthcare sector in 2009, the total market cap for Chinese healthcare companies has reached $145 billion with 185 companies listed globally, according to the first China Healthcare Valuation Map, developed by Morgan Stanley research group in Hong Kong
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).